Effects of Lipid-Lowering Agents in the Dahl Salt-Sensitive Rat

Hypertension

Volumn 31, Issue 1, 1998, Pages 225-231

  Wilson, Thomas W ^a   Alonso Galicia, Magdalena ^a   Roman, Richard J ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKANE 1 MONOOXYGENASE; ANTILIPEMIC AGENT; CHOLESTEROL; CLOFIBRATE; CYTOCHROME P450; FENOFIBRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MIXED FUNCTION OXIDASE; PRAVASTATIN; TRIACYLGLYCEROL; ARACHIDONIC ACID DERIVATIVE; ICOSANOID;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; BLOOD PRESSURE; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; FEMALE; GENETICS; GLOMERULUS; HYPERTENSION; KIDNEY; MALE; PATHOLOGY; PROTEINURIA; RAT; RAT STRAIN; SODIUM INTAKE; SODIUM RESTRICTION; WEIGHT GAIN; ANIMAL MODEL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIETARY INTAKE; HISTOLOGY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ALKANE 1-MONOOXYGENASE; ANIMALS; ANTILIPEMIC AGENTS; BLOOD PRESSURE; CHOLESTEROL; CLOFIBRATE; CYTOCHROME P-450 ENZYME SYSTEM; DIET, SODIUM-RESTRICTED; ENZYME INDUCTION; FEMALE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; KIDNEY; KIDNEY GLOMERULUS; MALE; MIXED FUNCTION OXYGENASES; PRAVASTATIN; PROCETOFEN; PROTEINURIA; RATS; RATS, INBRED STRAINS; SODIUM, DIETARY; TRIGLYCERIDES; WEIGHT GAIN;

EID: 0031611941     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.31.1.225     Document Type: Article

References (35)

1. Rapp JP, Dene H. Development and characterization of inbred strains of Dahl salt-sensitive and salt resistant rats. Hypertension. 1985;7:340-349.
2. Greene AS, Yu ZY, Roman RJ, Cowley AW Jr. Role of blood volume expansion in Dahl rat model of hypertension. Am J Physiol. 1990;258:H508-H514.
3. Roman RJ, Osborn JL. Renal function and sodium balance in conscious Dahl S and R rats. Am J Physiol. 1987;252:R833-R841.
4. Simchon S, Manger WM, Brown TW. Dual hemodynamic mechanisms for hypertension in Dahl salt-sensitive rats. Hypertension. 1991;17:1063-1071.
5. Roman RJ, Alonso-Galicia M, Wilson TW. Renal P450 metabolites of arachidonic acid and the development of hypertension in Dahl salt-sensitive rats. Am J Hypertens. 1997;10:63s-67s.
6. Roman RJ, Kaldunski ML. Pressure-natriuresis and cortical and papillary blood flow in inbred Dahl rats. Am J Physiol. 1991;261:R595-R602.
7. Roman RJ, Kaldunski ML. Enhanced chloride reabsorption in the loop of Henle of Dahl salt-sensitive rats. Hypertension. 1991;17:1018-1024.
8. Kirchner KA. Greater loop chloride uptake contributes to the blunted pressure-natriuresis in Dahl S rats. J Am Soc Nephrol. 1990;1:180-186.
9. Zou AP, Drummond JA, Roman RJ. Role of 20-HETE in elevating loop chloride reabsorption in Dahl SS/Jr rats. Hypertension. 1996;27:631-635.
10. Ma Y-H, Schwartzman ML, Roman RJ. Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats. Am J Physiol. 1994;267:R579-R589.
11. Escalante B, Erlij D, Falck JR, McGiff JC. Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science. 1991;251:799-801.
12. Stec DE, Mattson DL, Roman RJ. Inhibition of renal outer medullary 20-HETE production produces hypertension in Lewis rats. Hypertension. 1997;29:315-329.
13. Green S. PPAR: a mediator of peroxisome proliferator action. Mutat Res. 1995;333:101-109.
14. Roman RJ, Ma Y-H, Frolich B, Markham B. Clofibrate prevents the development of hypertension in Dahl salt-sensitive rats. Hypertension. 1993;26:985-988.
15. Jiang J, Stec DE, Drummond H, Simaon G, Koike G, Jacob H, Roman RJ. Transfer of a salt-resistant renin allele raises arterial pressure in Dahl salt sensitive rats. Hypertension. 1997;29:619-628.
16. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of serum cholesterol. Clin Chem. 1974;20:470-475.
17. McGowan MW, Artiss JD, Strandbergh DR, Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem. 1983;29:538-542.
18. Jeinegard D, Tiderstrom G. Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta. 1973;43:305-310.
19. Bradford, DM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
20. Kasiske BL, O'Donnell MP, Cleary MP, Keane WF. Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int. 1988;33:667-672.
21. Lee RMKW. Vascular changes at the prehypertensive phase in mesenteric arteries from spontaneously hypertensive rats. Blood Vessels. 1985;12:513-518.
22. Harder DR, Gebremedhin D, Narayanan J, Jefcoat C, Falck JR, Campbell WB, Roman RJ. Formation and action of a cytochrome P450 metabolite of arachidonic acid in cat cerebral microvessels. Am J Physiol. 1994;266:H2098-H2107.
23. Satoh T, Cohen HT, Katz AI. Regulation of Na-K-ATPase activity in the proximal tubule: role of eicosanoids. J Clin Invest. 1993;91:409-415.
24. + -ATPase through a cytochrome P450 pathway. Am J Physiol. 1994;266:F497-F505.
25. + -ATPase. J Clin Invest. 1997;99:1224-1230.
26. + channel in the thick ascending limb of the rat kidney. J Gen Physiol. 1995;106:727-743.
27. Alonso-Galicia M, Frohlich B, Roman RJ. Induction of renal P4504A activity with clofibrate normalizes pressure-natriuresis and prevents hypertension in Dahl S rats. Hypertension. 1997;30:509. Abstract.
28. Simon BC, Cunningham LD, Cohen RA. Oxidized low density lipoprotein causes contraction and inhibits endothelium dependent vasodilation in the pig coronary artery. J Clin Invest. 1990;86:75-79.
29. Luscher TF, Tanner FC, Noll G. Lipids and endothelial function: effects of lipid-lowering agents and other therapeutic interventions. Curr Opin Lipidol. 1996;7:234-240.
30. O'Donnell MP, Kasiske BL, Katz SA, Schmitz PG, Keane WF. Lovastatin but not enalapril reduces glomerular injury in the Dahl salt-sensitive rat. Hypertension. 1992;20:651-658.
31. Hughes AD. The role of isoprenoids in vascular smooth muscle: potential benefits of statins unrelated to cholesterol lowering. J Hum Hypertens. 1996;10:387-390.
32. 2+) responsiveness of smooth muscle contraction. FEBS Lett. 1993;324:211-215.
33. Indolfi C, Avvedimento EV, Rapacciuolo A, Di Lorenzo E. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nat Med. 1995;1:541-545.
34. Jiang J, Roman RJ. Lovastatin prevents the development of hypertension in spontaneously hypertensive rats. Hypertension. 1997;30:968-974.
35. Mene P, Simonson MS, Dunn MJ. Physiology of the mesangial cell. Physiol Rev. 1989;69:1347-1424.